Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Acta Biochimica Et Biophysica Sinica|October 28, 2024
CircMALAT1 promotes the proliferation and metastasis of intrahepatic cholangiocarcinoma via the miR-512-5p/VCAM1 axisMeixia Zhang, Mingyan He, Liangliang Bai, et al.
Lung Cancer (Amsterdam, Netherlands)|March 20, 2019
Cost-effectiveness analysis of atezolizumab plus chemotherapy in the first-line treatment of extensive-stage small-cell lung cancerKexun Zhou, Jing Zhou, Jiaxing Huang, et al.
Immunological Investigations|January 26, 2022
PCSK9 Suppresses M2-Like Tumor-Associated Macrophage Polarization by Regulating the Secretion of OX40L from Hepatocellular Carcinoma CellsJing Hu, Meixia Zhang, Ling Gui, et al.
Clinical Chemistry|February 10, 2019
Novel Assay for Quantitative Analysis of DNA Methylation at Single-Base ResolutionHuichuan Yu, Liangliang Bai, Guannan Tang, et al.
International Journal of Molecular Medicine|December 5, 2025
FBXO22 promotes hepatocellular carcinoma progression via paracrine myo‑inositol‑induced M2‑type polarization of macrophagesLiangliang Bai, Jing Xiong, Sihai Chen, et al.
Gastroenterology Research and Practice|December 31, 2020
Improved Survival Outcome and Access to Cancer Screening from Hemorrhoid in Patients with Rectal CancerQi Zou, Donglin Ren, Xiaolin Wang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 24, 2019
Cost-effectiveness analysis of cabozantinib as second-line therapy in advanced hepatocellular carcinomaWeiting Liao, Jiaxing Huang, David Hutton, et al.
Breast Cancer (Tokyo, Japan)|December 20, 2019
First-line fulvestrant plus anastrozole for hormone-receptor-positive metastatic breast cancer in postmenopausal women: a cost-effectiveness analysisWeiting Liao, Jiaxing Huang, Qiuji Wu, et al.
Journal of Diabetes Research|April 20, 2018
The Effects of Sleeve Gastrectomy on Glucose Metabolism and Glucagon-Like Peptide 1 in Goto-Kakizaki RatsLaiyuan Li, Xiaolin Wang, Liangliang Bai, et al.
ILIVER|July 10, 2025
Identification of positive cofactor 4 as a diagnostic and prognostic biomarker associated with immune infiltration in hepatocellular carcinomaLiangliang Bai, Guan Liu, Gang Dou, et al.
Pageof 5